A clinician nudge for referral to a gynecologic oncologist at the time of suspected ovarian cancer diagnosis improved referral rates by 20 percentage points, according to study results.Nearly a third ...
Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment paradigms in ovarian cancer.
The Healthy @Reader's Digest on MSN12h
9 Secrets Your Blood Type Reveals About YouYour blood type may be a window into your health. From heart disease and strokes to certain types of cancer, here's why blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback